Tissue factor as an initiator of coagulation and inflammation in the lung

T Van Der Poll - Critical Care, 2008 - Springer
Patients with severe infections almost invariably exhibit evidence of activation of the
coagulation system. The lungs are amongst the most frequently affected organs during …

[HTML][HTML] Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis

RJ José, A Williams, A Manuel… - European …, 2020 - Eur Respiratory Soc
Novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2), has rapidly spread throughout the world, resulting in a …

Systemic and local high mobility group box 1 concentrations during severe infection

MAD van Zoelen, PF Laterre, SQ van Veen… - Critical care …, 2007 - journals.lww.com
Objective: High mobility group box 1 (HMGB1) has been implicated as a late mediator in
sepsis. We here sought to determine the extent of HMGB1 release in patients with sepsis …

Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia

MAD van Zoelen, A Ishizaka, EK Wolthuis, G Choi… - Shock, 2008 - journals.lww.com
High-mobility group box (HMGB) 1 is a recently discovered proinflammatory mediator that
contributes to acute lung injury. We determined HMGB-1 levels in bronchoalveolar lavage …

Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress

JA Bastarache, SC Sebag, JK Clune, BS Grove… - Thorax, 2012 - thorax.bmj.com
Background Systemic blockade of tissue factor (TF) attenuates acute lung injury (ALI) in
animal models of sepsis but the effects of global TF deficiency are unknown. We used mice …

Feedback and education improve physician compliance in use of lung-protective mechanical ventilation

EK Wolthuis, JC Korevaar, P Spronk, MA Kuiper… - Intensive care …, 2005 - Springer
Objective Use of lung-protective mechanical ventilation (MV) by applying lower tidal
volumes is recommended in patients suffering from acute lung injury (ALI) or acute …

Effects of anticoagulant strategies on activation of inflammation and coagulation

C Feistritzer, CJ Wiedermann - Expert opinion on biological …, 2007 - Taylor & Francis
Acute inflammatory events, such as those that occur in sepsis, lead to dysregulation of the
coagulation cascade. The hemostatic imbalance in sepsis, characterized by the excessive …

S100A12 and soluble receptor for advanced glycation end products levels during human severe sepsis

A Achouiti, D Föll, T Vogl, JWO van Till, PF Laterre… - Shock, 2013 - journals.lww.com
ABSTRACT S100A12 is highly expressed, and serum levels correlate with individual
disease activity in patients with inflammatory diseases. We here sought to determine the …

Nebulized anticoagulants limit pulmonary coagulopathy, but not inflammation, in a model of experimental lung injury

JJ Hofstra, AP Vlaar, AD Cornet, B Dixon… - Journal of aerosol …, 2010 - liebertpub.com
Background: Pulmonary coagulopathy may contribute to an adverse outcome in lung injury.
We assessed the effects of local anticoagulant therapy on bronchoalveolar and systemic …

[PDF][PDF] Tissue factor in health and disease

JC Williams, N Mackman - Frontiers in Bioscience-Elite, 2012 - article.imrpress.com
Introduction 3. Tissue Factor and Coagulation 4. Tissue Factor and Protease Activated
Receptors 5. Tissue Factor and Development 6. Tissue Factor and Pregnancy 7. Tissue …